The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The Opioid Use Disorder (OUD) Market In 2026, And How Will Its Value Evolve By 2030?
The market size for opioid use disorder (OUD) has experienced substantial growth in recent years. It is projected to increase from $4.37 billion in 2025 to $4.89 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.8%. Historically, this expansion can be linked to the overprescription of opioid painkillers, the growing prevalence of chronic pain conditions, insufficient access to early addiction treatment, the social stigma associated with substance abuse treatment, and the increased availability of illicit opioids.
The opioid use disorder (oud) market size is projected to experience substantial growth over the coming years, reaching $7.82 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.5%. This projected expansion during the forecast period is primarily driven by factors such as increased government financial support for addiction treatment initiatives, a greater embrace of medication-assisted treatment, the proliferation of online and telehealth services for addiction, broadened insurance coverage for OUD therapies, and a heightened emphasis on strategies for prevention and harm reduction. Key developments anticipated in the forecast period involve a rising uptake of medication-assisted treatment programs, enhanced integration of behavioral therapy with pharmacological interventions, the ongoing expansion of community-based opioid treatment facilities, a growing focus on long-acting injectable treatments for OUD, and an increased commitment to preventing relapse and ensuring long-term recovery care.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp
What Key Drivers Are Fueling The Growth Of The Opioid Use Disorder (OUD) Market?
An increasing incidence of opioid addiction is anticipated to fuel expansion within the opioid use disorder (OUD) market. This addiction is defined as a chronic medical condition marked by an uncontrollable and persistent reliance on opioids, resulting in detrimental bodily effects. Opioids initially offer feelings of euphoria and pain alleviation, but their ongoing consumption often leads to tolerance, necessitating larger doses for the same impact, ultimately progressing to opioid use disorder. For example, data from the Centers for Disease Control and Prevention, a US public health agency, indicates that in 2023, there were 79,358 drug overdose deaths linked to any opioid. Furthermore, the rate of such deaths was 23.7 per 100,000 population. Consequently, the rising instances of opioid addiction are a key factor driving the growth of the opioid use disorder (OUD) market.
Which Segment Types Are Examined In The Opioid Use Disorder (OUD) Market Segment Study?
The opioid use disorder (oud) market covered in this report is segmented –
1) By Drug Type: Buprenorphine, Naltrexone, Methadone
2) By Route Of Administration: Oral, Parenteral
3) By Age Group: 19 To 40, 41 To 60, 61 And Over
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies
Subsegments:
1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film
2) By Naltrexone: Naltrexone Tablets, Vivitrol
3) By Methadone: Methadone Tablets, Methadone Oral Solution
What Trends Are Influencing The Opioid Use Disorder (OUD) Market?
Leading companies active in the opioid use disorder (OUD) market are focusing on developing innovative solutions, such as next-generation extended-release buprenorphine formulations, to meet the increasing demand for long-acting, adherence-supportive treatment options that reduce withdrawal symptoms and improve recovery outcomes. Extended-release buprenorphine formulations provide sustained medication delivery over weekly or monthly intervals, offering greater convenience and stability compared with daily oral or sublingual therapies that may increase relapse risk. For instance, in May 2023, the U.S. Food and Drug Administration, a US-based federal agency, approved Brixadi (buprenorphine) extended-release injection for the treatment of moderate to severe opioid use disorder (OUD). Brixadi is available in two dosage forms: a weekly injection for patients who initiated treatment with a single dose of a transmucosal buprenorphine product or are currently taking the medication, and a monthly version for those who are already receiving the medication.
Which Players Are Part Of The Competitive Landscape Of The Opioid Use Disorder (OUD) Market?
Major companies operating in the opioid use disorder (oud) market are Indivior Plc., Alkermes Inc., Braeburn Pharmaceuticals Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo US Inc., Rhodes Pharmaceuticals L P, Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals Plc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Mylan NV, Adapt Pharma Inc., Opiant Pharmaceuticals Inc., Dr Reddy’s Laboratories Ltd., Cipla Limited, Luye Pharma Group, Amneal Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Knight Therapeutics, BioCorRx Inc., Lannett Company Inc., Zydus Cadila, Apotex Inc., Intas Biopharmaceuticals, Glenmark Pharmaceuticals Ltd., InterveXion Therapeutics
Get The Full Opioid Use Disorder (OUD) Market Report:
https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report
Where Is The Opioid Use Disorder (OUD) Market Primarily Concentrated By Region?
North America was the largest region in the opioid use disorder (OUD) market in 2025. The regions covered in the opioid use disorder (oud) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Opioid Use Disorder (OUD) Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report
Browse Through More Reports Similar to the Global Opioid Use Disorder (OUD) Market 2026, By The Business Research Company
Ophthalmic Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report
Ophthalmology Drugs Market
https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-market
Ophthalmic Eye Dropper Market Report
https://www.thebusinessresearchcompany.com/report/ophthalmic-eye-dropper-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model